WitrynaImatinib mesilate The active substance is the mesylate salt form of imatinib, a phenylaminopyrimidine derivative and is the 4-[(4-methyl-1-piperazinyl) methyl] – N – [4-methyl-3-[ [4-(3-pyridinyl)-2-pyrimidinyl] amino]-phenyl]-benzamide methanesulfonic acid salt. It is a white to slightly yellowish crystalline powder and WitrynaWC,COA,MOA,DMF,SDS,MSDS,LOCAL GMP,DML,ISO9001 certificated, etc.. 8 production lines, 12 years experience, 2800 ㎡ R&D building，etc Our main products cover Ganciclovir,Sitagliptin,Empagliflozin, Imatinib mesylate,Silodosin，Molnupiravir..etc as API and its Intermediate. Waiting for you …
Product Information for Glivec
WitrynaSAFETY DATA SHEET Creation Date 03-Mar-2016 Revision Date 24-May-2024 … Witryna15 wrz 2006 · Survival rates with imatinib mesylate were significantly better than with interferon-α within each of the CML prognostic risks groups. By multivariate analysis, imatinib mesylate therapy was identified as an independent favorable prognostic factor, after accounting for the impact of pretreatment factors (hazard ratio, 0.44; P < .01). By ... inception myflixer
Imatinib mesylate - Safety Data Sheet
WitrynaMaterial Imatinib Mesylate Tablets 100 mg and 400 mg Manufacturer NATCO … WitrynaImatinib is approximately 95% bound to human plasma proteins, mainly albumin and alpha1-acid glycoprotein. The drug is eliminated predominantly via the bile in the form of metabolites, one of which (CGP 74588) shows comparable pharmacological activity to the parent drug. The faecal to urinary excretion ratio is approximately 5:1. Witryna15 lip 2024 · Look through Imatinib mesylate MSDS details show. We provide … inception mv vlive